publication venue for Safety and early efficacy outcomes for lentiviral fibroblast gene therapy in recessive dystrophic epidermolysis bullosa. 4:1-20. 2019 Deep sequencing reveals microRNAs predictive of antiangiogenic drug response. 1:1-10. 2016
